Children who have severe and persistent
juvenile idiopathic arthritis (JIA), during or even
after treatment, may be considered for therapies that have been proved to be
safe and effective for adult
rheumatoid arthritis or other
autoimmune disease but have yet to be fully studied
for juvenile idiopathic arthritis. Examples of such therapies include:
Giannini EH, Brunner HI (2005). Treatment of juvenile rheumatoid arthritis. In WJ Koopman, LW Moreland, eds., Arthritis and Allied Conditions, 15th ed., vol. 1, pp. 1301–1318. Philadelphia: Lippincott Williams and Wilkins.
Weiss JR, Ilowite NT (2005). Juvenile idiopathic arthritis. Pediatric Clinics of North America, 52(2): 413–442.
ByHealthwise StaffPrimary Medical ReviewerSusan C. Kim, MD - PediatricsBrian D. O'Brien, MD - Internal MedicineMartin J. Gabica, MD - Family MedicineE. Gregory Thompson, MD - Internal MedicineKathleen Romito, MD - Family MedicineSpecialist Medical ReviewerJohn Pope, MD - Pediatrics
Current as ofOctober 31, 2016
Current as of:
October 31, 2016
Susan C. Kim, MD - Pediatrics
& Brian D. O'Brien, MD - Internal Medicine & Martin J. Gabica, MD - Family Medicine & E. Gregory Thompson, MD - Internal Medicine & Kathleen Romito, MD - Family Medicine & John Pope, MD - Pediatrics
To learn more about Healthwise, visit Healthwise.org.
© 1995-2017 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.